• Contact Us
  • Site Map
  • Terms of Use & Privacy Policy
  • MiddleBrook Career Opportunities
  • Prescribing Information

Keflex


  • Convenience
  • Compliance
  • Confidence
  • FAQ
  • Contact Us

Site Map

Keflex® 750 mg Homepage

Convenience

Compliance

Confidence

FAQ

Contact Us

Full Prescribing Information

Terms & Conditions

Privacy Policy

References

 

  • Contact Us
  • Site Map
  • Terms of Use & Privacy Policy
  • MiddleBrook Career Opportunities
  • Prescribing Information

KEFLEX is indicated for the treatment of respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections in adults and children six months and older.

Important Safety Information
KEFLEX is contraindicated in patients with known allergy to the cephalosporin group of antibiotics. Before therapy with cephalexin is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to cephalexin, cephalosporins, penicillins, or other drugs. KEFLEX should be administered with caution in the presence of markedly impaired renal function or a history of gastrointestinal disease, particularly Clostridium difficile associated diarrhea (CDAD).

KEFLEX is a registered trademark of MiddleBrook Pharmaceuticals, Inc.
© 2007 MiddleBrook Pharmaceuticals, Inc. All Rights Reserved.

904-0606-0017r

MiddleBrook Pharmaceuticals, Inc.